Records containing: Neoplasms, Pulmonary
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-18A Phase Ib/II Open-label, Multi-center Dose Escalation Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
-
CLINICAL_TRIALS study record update · 2026-02-23Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities
-
CLINICAL_TRIALS study record update · 2025-10-14Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2023-10-10Feasibility and Acceptability of Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®
-
CLINICAL_TRIALS study record update · 2023-10-04MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-09-28A Phase I Study of iPS Cell Generation From Patients With COPD
-
CLINICAL_TRIALS study record update · 2021-07-21Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer
-
CLINICAL_TRIALS study record update · 2018-03-21A Pilot Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
-
CLINICAL_TRIALS study record update · 2015-11-23The Need and the Effectiveness of Fiberoptic Bronchoscopy for Better Lung Collapse in Vedio-assisted Thoracic Operations Using Endobronchial Blockers
-
CLINICAL_TRIALS study record update · 2007-06-08A Phase 3, Randomized, Double-Blind, Multicenter Study of Talabostat and Pemetrexed vs. Pemetrexed and Placebo in Patients With Advanced (Stage IIIB/IV) Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy